Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Adalimumab in Early Axial Spondyloarthritis (Without Radiological Sacroiliitis): Placebo Controlled Phase Over 3 Months Followed by a 9 Months Open Extension Phase

NCT00235105 is registered in ClinicalTrials.gov with Charite University, Berlin, Germany as lead sponsor.

NCT NCT00235105
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00235105 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Adalimumab in Early Axial Spondyloarthritis (Without Radiological Sacroiliitis): Placebo Controlled Phase Over 3 Months Followed by a 9 Months Open Extension Phase
Lead sponsor
Charite University, Berlin, Germany
Phase
Phase 2/3
Overall status
Unknown status
Start date
March 31, 2005
Completion date
June 30, 2007
Enrollment
46
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

ankylosing spondylitis